To investigate cell type-specific alterations in fatty acid metabolism-related genes in the dorsolateral prefrontal cortex of schizophrenia patients and evaluate their potential as diagnostic biomarkers, focusing on their role in disease mechanisms.
Key Findings:
Specific neuronal subtypes (CUX2+ NeuN and OPRM1+ NeuN) were significantly upregulated in SCZ, indicating a potential target for further research.
Differentially expressed genes were enriched in fatty acid metabolism pathways, suggesting a link between metabolism and SCZ pathology.
Five key genes (ACAA1, ACAT2, ACSS1, PSME1, S100A10) were identified as associated with SCZ pathogenesis, warranting further investigation.
The diagnostic model showed AUC of 0.856 in training and 0.779 in validation cohorts, indicating reliable predictive performance and potential clinical application.
Interpretation:
The study highlights cell type-specific dysregulation of fatty acid metabolism in schizophrenia, suggesting a potential pathway for diagnosis and understanding disease mechanisms.
Limitations:
The sample size for single-cell sequencing was relatively small, which may limit the robustness of the findings.
The study primarily focused on the dorsolateral prefrontal cortex, limiting generalizability to other brain regions and necessitating further studies.
Conclusion:
The findings provide a robust five-gene diagnostic model with translational potential for schizophrenia, emphasizing the role of fatty acid metabolism in the disease and suggesting avenues for future research.
